From Judging the Decision to Evaluating the Decision

There was a time when I had a pretty firm opinion about GLP-1 medications.

If you had a medical condition and needed one, I understood it. If you were taking one just to lose a few pounds, I questioned it.

My thinking has changed.

Not because I suddenly believe everyone should take a GLP-1. I don’t. Personally, I wouldn’t take one just to lose a few “vanity pounds.”

What changed is that I stopped looking at the medication first.

I started looking at the person.

Instead of asking, “Why are you taking that?” maybe we should ask:

What are you trying to treat? What are your risk factors? What does your family history look like? What are the risks of doing nothing?

Do the potential benefits outweigh the risks of the medication?

That’s the difference between judging the decision and evaluating the decision.

This is bigger than weight loss

GLP-1–based medications affect appetite, satiety, glucose regulation and digestion. For the right person, the benefits can extend well beyond losing weight.

In the SELECT trial, semaglutide reduced major cardiovascular events by about 20% in people with overweight or obesity and established cardiovascular disease who did not have diabetes.

That matters.

Someone dealing with obesity, rising blood glucose, hypertension, sleep apnea and a strong family history of diabetes is having a very different conversation from someone who wants to lose ten pounds before vacation.

Same medication.

Different person. Different risks. Different decision.

Taking medication isn't a moral failure

Weight is one of the few health issues we still attach heavily to character.

We talk about discipline. Willpower. Motivation. Trying harder.

Yet we don't look at someone taking blood pressure medication and say, “You should have tried harder.”

Someone considering a GLP-1 may have spent years losing and regaining weight. Their metabolic health may be worsening. Their cardiovascular risk may be increasing. Exercise and nutrition may already be part of their life.

We don't know someone's entire medical history by looking at their body.

Medication isn't automatically the easy way out. Sometimes it's simply treatment.

Treatment still has risks

Compassion doesn't mean ignoring the medical concerns.

GLP-1 medications can cause nausea, vomiting, diarrhea, constipation and other gastrointestinal problems. Less common but more serious complications can include pancreatitis, gallbladder disease, kidney problems related to dehydration and severe gastrointestinal reactions. Certain medications in this category also carry specific warnings and contraindications that should be discussed with a healthcare provider.

That is why this shouldn't be a casual decision.

The question isn't simply:

“Can I get the medication?”

It should be:

“Does this medication make sense for me?”

Losing weight isn't the only outcome that matters

This may be the part of the GLP-1 conversation I care about most.

If someone loses 40 pounds, I don't just want to know what the scale says.

What happened to your strength?

What happened to your muscle?

Are you eating enough?

Are you getting adequate protein and nutrients?

Are you resistance training?

Can you move better?

Did your blood pressure improve?

Did your blood glucose improve?

Are you healthier and more physically capable?

Weight loss can include lean tissue as well as body fat. That makes adequate nutrition and resistance exercise especially important during significant weight loss.

The goal shouldn't simply be to become smaller. The goal should be to become healthier while protecting the body you're going to live in afterward.

What about the “vanity pounds”?

Personally, I wouldn't take a GLP-1 simply because I wanted to lose a small amount of weight for appearance.

For me, the potential benefit wouldn't justify taking a medication.

That's my risk-benefit calculation.

Someone else's decision isn't mine to judge.

I can still ask whether they understand the risks, whether the medication is medically appropriate, whether there are lower-risk options and whether they're being properly monitored.

That's evaluation.

Judgment sounds like:

“You shouldn't be taking that.”

Evaluation asks:

“What are you taking it for, and does the benefit justify the risk for you?”

There's a big difference.

Maybe we're asking the wrong question

GLP-1 medications aren't inherently good or bad.

They're medications.

For one person, the answer may be:

No. The potential benefit probably doesn't justify the risk.

For another:

Yes. This could meaningfully improve your health and reduce your future risk.

Both answers can be reasonable.

So I've changed my position.

I'm less interested in asking whether someone should be taking a GLP-1 based on what I can see from the outside.

I'm more interested in the person behind the prescription.

Their health.

Their history.

Their risk factors.

Their goals.

Their reason for taking it.

Let's stop judging the decision and start evaluating the decision.

The goal isn't to determine whether someone is disciplined enough to lose weight without medication.

The goal is to determine whether the treatment makes sense for that individual and whether it's helping them become healthier, not simply smaller.